Tag: Subtle Screening

Elevated RAP/ High Probability Results on an Adult SASSl-4

This profile on a 21-year-old female with the FVA and FVOD, based on the last 12 months, is interesting primarily because it is so unusual.

As you look at the profile graph, all the scale scores are within the norm, i.e., between the 15th and 85th percentiles except for the SYM score which is above the 85th percentile. This tells you that she is acknowledging symptoms and consequences of her use and indicates she is associating with friends or family who are also heavy users. This is a bit of a contrast to her FVA and FVOD scores, both of which are above average but not above the 85th percentile.

The SAT score of 5 is within the norm which is a positive – no denial or lack of awareness or insight is indicated. However, with the OAT score within the norm, it is a possibility that she does not identify with other substance users and those characteristics we associate with substance users such as impatience, self-pity, resentment, or impulsivity. If marijuana is her primary drug, she may not see it as a problem so the high probability of a substance use disorder may be an unexpected result for the client.

Another positive is the DEF score, which is above average but not clinically significant since it is below the 85th percentile.

The client meets decision rules 5, 6 and 9 and 10 thus meeting the criteria for a high probability of a substance use disorder. As a reminder, more rules that are met does not mean a more severe problem. As we often mention on the clinical helpline, the diagnosis and severity of a substance use disorder is based on the criteria in the DSM-5.

Note the Prescription Drug Scale score of 2. It does not meet the cut-off criteria for prescription drug abuse, but it is worth a look at those items she endorsed.

The caller was puzzled by the RAP score of 2 and how it affected the result of the SASSI.

A RAP score of 2 or more always needs to be explored, preferably with the client. The two items which posed the problem were ‘I never have been picked on and I have never been sad’.
Cultural and language contexts need to be considered for possible reasons the client answered as she did. The possibility of her deliberately trying to ‘skew’ the questionnaire is low given the high probability result. More likely, the client answered accurately for her based on her life experience.

The clinician can now safely accept the overall result as valid.

As a reminder, the free clinical helpline, (800-726-0526) is available M-F, 12- 5 pm (EST) for any questions you may have. We also offer a free Q&A zoom meeting once a month for an hour as well. Please check the blog notice for dates and time to register. And finally, if you have additional inquiries, please contact the Clinical Director, Kristin Kimmell, LCSW, LCAC at kristin@sassi.com.

PDF Version Available for Download

What is a Substance Use Disorder Screening Instrument and the SASSI

A substance use disorder screening instrument is a tool that is used to identify individuals who may be struggling with substance abuse or addiction. There are several different types of screening instruments that may be used, but one of the most common is the Substance Abuse Subtle Screening Inventory (SASSI).

The SASSI is a self-administered questionnaire that asks a series of questions related to an individual’s past and current use of drugs and alcohol, as well as their behavior and attitudes related to substance abuse. The questions are designed to identify patterns of behavior that may be indicative of a substance use disorder, such as a tendency to lie about drug or alcohol use, or a history of legal or financial problems related to substance abuse.

The SASSI also includes subtle scales which help to identify individuals who may be attempting to conceal their drug and alcohol use. There are several benefits to using the Substance Abuse Subtle Screening Inventory (SASSI) as a substance use disorder screening instrument:

  • Standardization: The SASSI is a standardized tool that has been extensively researched and validated. This means that it provides a consistent and reliable method for identifying individuals who may be struggling with substance abuse.
  • Efficiency: The SASSI can be administered quickly and easily, either in paper or electronic format. This makes it a convenient tool for screening large groups of people, such as in a primary care or community health setting.
  • Sensitivity: The SASSI is designed to be sensitive to a wide range of substance use disorders, including those that may not be immediately apparent to healthcare providers or other professionals.
  • Validity: The SASSI subtle scales increase the accuracy of the results and ensure that individuals receive appropriate treatment based on their level of need.
  • Flexibility: The SASSI can be used with a variety of populations, including adults, adolescents, and those with co-occurring mental health disorders.

Overall, the SASSI provides a useful tool for healthcare providers, substance abuse professionals, criminal justice entities and others who are involved in identifying and treating substance use disorders. It can help to ensure that individuals receive appropriate care and support, which can ultimately improve their health and well-being.

Clinical Q&A and Live SASSI Training Webinar 

We are pleased that people have been joining us for our free one-hour online Clinical Q&A sessions hosted by our Clinical Director, Kristin Kimmell, LCSW, LCAC.  

We enjoy hearing how you are using the SASSI in your clinical practice and agencies as well as answering your questions and speaking to you all.  We have scheduled additional sessions that we hope you can join in on. You can reserve your spot and view available dates and times by clicking here. If you have profiles you would like to share with the group for discussion, please send them (de-identified) via email any time prior to the session to scarlett@sassi.com. Your contributions would be of great value. Also, a reminder that we have a live webinar on Administration & Scoring of the paper & pencil version of the SASSI on April 18th and Clinical Interpretation on April 25th. You can register by clicking here.   

Note that the Q&A sessions do not provide CEUs and are not a substitute for SASSI Training. SASSI training provides 3.5 NAADAC CEs per session. 

We hope to see you there! 

REMINDER: More Live Clinical Q&A Sessions Coming Up

Please join us for our free Clinical Q&A sessions online. The sessions are hosted by our Clinical Director, Kristin Kimmell, LCSW, LCAC, and last approximately one-hour. We invite you to ask questions or share experiences regarding unusual or difficult profiles you may have come across. However, all questions are welcome. We would be delighted if you have profiles you would like to share with the group for discussion. Please send them (de-identified) via email any time prior to the session to scarlett@sassi.com. Your contributions would be of great value.

The next upcoming dates are Tuesday, February 21st and Tuesday, March 21st from 1-2 pm ET. Click here to register today.

Note that these Q&A sessions do not provide CEUs and are not a substitute for SASSI Training.

See you there!

SASSI Online Tips and Tricks: Volume 4 | Unassigning (deleting) or Redelivering an Incomplete Questionnaire

In this edition of SASSI Online Tips and Tricks we look at answering one of our commonly asked Tech Support questions; how to unassign (delete) or redeliver an incomplete questionnaire.

Read more

SASSI Training

As we prepare to move into 2023, we are excited that our certified SASSI trainers throughout the U.S. and Canada have begun doing live in-person trainings again and with more frequency. We invite you to check out our training page to view a list of currently scheduled workshops at https://sassi.com/sassi-training/.  These lists are updated frequently and also contain contact information for your local trainer/s. If nothing is scheduled in your area, we encourage you to reach out directly to the trainer so they know there is interest in their area. We also continue to offer online training webinars both live and on-demand if in-person is not a viable option for you.

Reminder: Our clinical team is available M-F to answer questions about the administration, scoring, and interpretation of our instruments at 800.726.0526 option 2. This is a free service, and we encourage you to call often.

Happy holidays to all.

Registration Open for more FREE LIVE Clinical Q&A Sessions

Please join us for one of our new Clinical Q&A sessions online. The Q&A is hosted by our Clinical Director, Kristin Kimmell, LCSW, LCAC, and lasts one-hour. We invite you to ask questions or share experiences regarding unusual or difficult profiles you may have come across, but all questions are welcome. You can also join just to listen to the group discussion.

Join us for one or both sessions. There are two dates currently scheduled: Tuesday, November 15th and Tuesday, December 13th from 1-2 pm ET. Click here to register today. Due to time constraints, each session will be limited to the first 25 registrants. As new dates are added we will post them to our blog page or you can check the registration page via the link within this blog.

Note that these Q&A sessions do not provide CEUs and are not a substitute for SASSI Training.

See you there!

Pre-employment Screening / A Profile Review on the Proper Use of the SASSI-4

A recent caller wanted help in interpreting a profile completed by a 33-year-old male. He was instructed to complete the FVA/FVOD side of the questionnaire for the last 12 months. The administrator revealed during the call that the assessment was a pre-employment screening for the Department of Transportation. The helpline does receive regular calls from counselors who administer the SASSI-4 for the Department of Transportation after a driver has failed a drug or alcohol test for substances, but not for pre-employment screening.

In review, the client comes up with a high probability of a substance use disorder based on Rules 2,5,6 and 9. The RAP is 0 and the Rx Prescription Drug Scale is 0.

The FVA is below average use, the FVOD is on the 50th percentile. The SYM scale of 7 is above the 85th percentile, considered elevated and thus Rule 2 meets the criteria of a High Probability of a Substance Use Disorder. The rest of the scale scores are within the norm (between 15-85th percentiles) so clinically are not significant but are significant in meeting the criteria of a Substance Use Disorder if accounting for the additional rules of # 5, 6 and 9. The SAT of 5, being in the norm indicates the client was not in denial about his usage.

Considerations

Although the results do not account for current or actual use, further assessment may include urine screens that would give a more accurate representation of current use of substances. He does come up with a high probability of a Substance Use Disorder, so deeper inquiry is necessary.

The administration of this SASSI was part of a pre-employment screening and our position on the proper use of the SASSI in this regard, is very explicit:

From our User’s Guide and Manual: *

“The purpose of the SASSI is to help identify people who are likely to have substance use disorders so that early intervention and treatment can be initiated when appropriate.”

“To use the SASSI to discriminate against individuals violates the intent of the authors and may even violate the law.”

“SASSI results should not be used to abridge the rights of individuals or to disqualify applicants for positions, such as jobs or benefits, such as public assistance programs.”

Thus, it is extremely important to use the results in the most therapeutic way possible with the best intentions of helping individuals with a substance use disorder.

If you have any questions, please contact the Clinical Director, Kristin S. Kimmell, LCSW, LCAC at kristin@sassi.com.

*SASSI -4 User Guide & Manual – Chapter 1 (overview), pg.7
SASSI-4 Online User Guide – Proper Use of the SASSI. pg. 8

FREE LIVE Clinical Q&A Registration Open

As discussed in a prior blog, we are expanding our free clinical phone service by offering free live clinical Q&A sessions online. These Q&A sessions are open to everyone. The Q&A will be hosted by our Clinical Director, Kristin Kimmell, LCSW, LCAC, and will last one-hour. We invite you to ask questions or share experiences regarding unusual or difficult profiles you may have come across, but all questions are welcome. You can also join just to listen to the group discussion.

Our first free Q&A session is scheduled for Tuesday, October 4th from 1-2 pm ET. Click here to register today. Due to time restraints, the session will be limited to the first 25 registrants. As new dates are added we will post them to our blog or you can check the registration page via the link above in this blog.

Note that this Q&A does not provide CEUs and is not a substitute for SASSI Training.

We hope you will join us!

Coming Soon: LIVE Clinical Q&A Sessions

Since the release of the original SASSI in the late 80’s we have had the pleasure of providing free clinical consultation and support for those using our instruments via our toll-free phone line. Our clinicians have enjoyed speaking with professionals about SASSI results and strive to make it a useful and pleasant experience. We are planning to expand on this service by offering free live clinical Q&A sessions online. We invite users of our instruments, those considering implementing our instruments, and students, to join our Clinical Director, Kristin Kimmell, LCSW, LCAC, for these FREE live one-hour sessions. Here you will be able to ask questions or share experiences regarding unusual or difficult profiles you may have come across, but all questions are welcome. You can also join in simply to listen to the group discussion and are not required to ask questions.

We hope this will be a useful expansion of our clinical service and look forward to having engaging group discussions. We believe we can learn from you as well and these discussions will help us be sure that our research is up to date with current concerns in the field of SUD. We will be announcing the date, time and registration information for our first Clinical Q&A next month on our Blog so be on the lookout for it!